2613|8121|Public
2500|$|Etanercept (trade name Enbrel) is a {{biopharmaceutical}} {{that treats}} autoimmune diseases by interfering with tumor necrosis factor (TNF; a soluble <b>inflammatory</b> <b>cytokine)</b> by {{acting as a}} TNF inhibitor. It has U.S. F.D.A. approval to treat rheumatoid arthritis, juvenile rheumatoid arthritis and psoriatic arthritis, plaque psoriasis and ankylosing spondylitis. TNF-alpha is the [...] "master regulator" [...] of the inflammatory (immune) response in many organ systems. Autoimmune diseases are caused by an overactive immune response. Etanercept {{has the potential to}} treat these diseases by inhibiting TNF-alpha.|$|E
2500|$|Caspase-4 and -5 in humans, and Caspase-11 in mice have {{a unique}} role as a receptor, whereby it binds to LPS, a {{molecule}} abundant in gram negative bacteria. This {{can lead to the}} processing and secretion of IL-1β and IL-18 cytokines by activating Caspase-1; this downstream effect is the same as described above. It also leads to the secretion of another <b>inflammatory</b> <b>cytokine</b> that is not processed. This is called pro-IL1α. There is also evidence of an inflammatory caspase, caspase-11 aiding cytokine secretion; this is done by inactivating a membrane channel that blocks IL-1β secretion ...|$|E
5000|$|KSHV <b>inflammatory</b> <b>cytokine</b> {{syndrome}} - a syndrome with MCD-like symptoms {{but without}} associated pathology.|$|E
25|$|Integrin ligands ICAM-1 and VCAM-1 are {{activated}} by <b>inflammatory</b> <b>cytokines,</b> while ICAM-2 is constitutively expressed by some endothelial cells but downregulated by <b>inflammatory</b> <b>cytokines.</b> ICAM-1 and ICAM-2 share two homologous N-terminal domains; both can bind LFA-1.|$|R
40|$|Objective: To {{report the}} effect of {{ketamine}} treatment on <b>inflammatory</b> <b>cytokines</b> induced by lipopolysaccharide. Methods: Human umbilical vein endothelial cells culture {{was used in this}} research. The measurement of <b>inflammatory</b> <b>cytokines</b> was performed by using ELISA. Results: The results showed various levels of <b>inflammatory</b> <b>cytokines.</b> The nuclear factor-κB results were unstable, but interleukin 6 and tumor necrosis factor-α showed similar results. The expressions of interleukin 6 and tumor necrosis factor-α decreased in all observation times. Conclusions: In general, our results of human umbilical vein endothelial cells culture were supported by other researches related with {{the effect of}} ketamine in suppressing inflammatory effect induced by lipopolysaccharide. Ketamine could suppress <b>inflammatory</b> <b>cytokines</b> in all observation time...|$|R
40|$|Although <b>inflammatory</b> <b>cytokines</b> {{induced by}} {{infection}} or vaccination with adjuvants {{have long been}} known to stimulate optimal antigen-presenting cell function, recent evidence indicates that some <b>inflammatory</b> <b>cytokines</b> also act directly on the responding T cells to control their response to infection. Here, we review the evidence that specific <b>inflammatory</b> <b>cytokines</b> act to control the magnitude of expansion, the degree of contraction, {{and the rate of}} memory cell development. These data may suggest new strategies for manipulating vaccine efficacy in the quest to protect against pathogenic microbes...|$|R
50|$|Also, insulin {{resistance}} often {{is associated with}} a hypercoagulable state (impaired fibrinolysis) and increased <b>inflammatory</b> <b>cytokine</b> levels.|$|E
50|$|On {{the other}} hand, {{disturbances}} {{in the structure}} and functioning of microglia cells and pathophysiological levels of the <b>inflammatory</b> <b>cytokine</b> interleukin-1 in the brain underlie the impairments in cognition and neurogenesis associated with stress.|$|E
50|$|Interleukin 13 (IL-13) is a {{pleiotropic}} cytokine {{that may}} be important in the regulation of the inflammatory and immune responses. It inhibits <b>inflammatory</b> <b>cytokine</b> production and synergises with IL-2 in regulating interferon-gamma synthesis. The sequences of IL-4 and IL-13 are distantly related.|$|E
5000|$|... neutral ceramidase (ASAH2, ASAH2B, ASAH2C) - {{protective}} against <b>inflammatory</b> <b>cytokines</b> ...|$|R
40|$|Neovascularization of the {{normally}} avascular cornea {{was associated with}} a notable increase in the expression of the major pro-angiogenic factors, <b>inflammatory</b> <b>cytokines</b> and proteases. The data supporting a causal role for vascular endothelial growth factor (VEGF), <b>inflammatory</b> <b>cytokines</b> and matrix metalloproteinase (MMPs) are extensive. Anti-angiogenic/anti-inflammatory therapy is considered as a possible tool for controlling corneal neovascularization. Mushroom Ganoderma Lucidum extracts containing materials that significantly reduced the number of newly formed vessels and expression of <b>inflammatory</b> <b>cytokines</b> and angiogenic factors production from various cells. This study aimed to elucidate anti-angiogenic activity of Ganoderma Lucidum extract for inhibiting corneal neovascularization and restoration of corneal neovascularization and restoration...|$|R
50|$|Cathepsin K {{expression}} is stimulated by <b>inflammatory</b> <b>cytokines</b> that are released after tissue injury.|$|R
50|$|Interleukin-31 (IL-31) is {{a protein}} that in humans is encoded by the IL31 gene that resides on {{chromosome}} 12. IL-31 is an <b>inflammatory</b> <b>cytokine</b> that helps trigger cell-mediated immunity against pathogens. It {{has also been}} identified as a major player in a number of chronic inflammatory diseases, including atopic dermatitis.|$|E
5000|$|Interleukin 31 is an <b>inflammatory</b> <b>cytokine</b> {{produced}} by activated CD4+ T lymphocytes, in particular activated TH2 helper cells, mast cells, macrophages, and dendritic cells. It major sites of action are the skin, lung, intestine and the nervous system. [...] Hence IL-31 main {{role is to}} facilitate cell-mediated immunity against pathogens.|$|E
50|$|Infliximab {{can reduce}} pain and {{arthritis}} in PDP. It is a monoclonal antibody that blocks the biological action of TNF-α (tumor necrosis factor-alpha). TNF-α is an <b>inflammatory</b> <b>cytokine</b> found in high levels in PDP {{and it is}} involved in the production of other inflammatory mediators which increase the expression of RANKL. RANKL is thought to increase bone resorption.|$|E
40|$|In acute {{myocardial}} infarction (MI), reactive oxygen species (ROS) are generated in the ischaemic myo-cardium especially after reperfusion. ROS directly injure the cell membrane and cause cell death. However, ROS also stimulate signal transduction to elaborate <b>inflammatory</b> <b>cytokines,</b> e. g. tumour necrosis factor-a (TNF-a), interleukin (IL) - 1 b and- 6, in the ischaemic region and surrounding myocar-dium as a host reaction. <b>Inflammatory</b> <b>cytokines</b> also regulate cell survival and cell death in the chain reaction with ROS. Both ROS and <b>inflammatory</b> <b>cytokines</b> are cardiodepressant mainly due to impair-ment of intracellular Ca 2 þ homeostasis. <b>Inflammatory</b> <b>cytokines</b> stimulate apoptosis through a TNF-a receptor/caspase pathway, whereas Ca 2 þ overload induced by extensive ROS generation causes necrosis through enhanced permeability of the mitochondrial membrane (mitochondrial permeability tran-sition). Apoptosis signal-regulating kinase- 1 (ASK 1) is an ROS-sensitive, mitogen-activated protein kinase kinase kinase that is activated by many stress signals and can activate nuclear factor kB and other transcription factors. ASK 1 -deficient mice demonstrate that the ROS/ASK 1 pathway is involved in necrotic as well as apoptotic cell death, indicating that ASK 1 may be a therapeutic target to reduce left ventricular (LV) remodelling after MI. ROS and <b>inflammatory</b> <b>cytokines</b> activate matrix metalloproteinases which degrade extracellular matrix, causing a slippage of myofibrils and hence L...|$|R
30|$|To {{find the}} role of MDSCs in sepsis and their {{relationship}} with the <b>inflammatory</b> <b>cytokines.</b>|$|R
5000|$|... and for elucidating the {{involvement}} of <b>inflammatory</b> <b>cytokines</b> in regulation of cognitive and emotional processes.|$|R
5000|$|... α5β1 is an {{integrin}} {{that binds}} to matrix macromolecules and proteinases and thereby stimulates angiogenesis. [...] It {{is composed of}} α5 (ITGA5/CD49e) and β1 (ITGB1/CD29) subunits. It is the primary receptor for fibronectin. The interaction of VLA-5 with fibronectin {{plays an important role}} in regulating <b>inflammatory</b> <b>cytokine</b> production by human articular chondrocytes (From the Cell Migration Gateway ITGA5 ITGB1).|$|E
5000|$|A proinflammatory {{cytokine}} or an <b>inflammatory</b> <b>cytokine</b> {{is a type}} of cytokine (signaling molecule) that is excreted from {{immune cells}} and certain other cell types that promotes inflammation. Inflammatory cytokines are predominately produced by helper T cells (Th) and macrophages and involved in the upregulation of inflammatory reactions. [...] Therapies to treat inflammatory diseases include monoclonal antibodies that either neutralize inflammatory cytokines or their receptors.|$|E
5000|$|A study {{published}} in 2007 suggested {{that the act of}} performing a Pap smear produces an <b>inflammatory</b> <b>cytokine</b> response, which may initiate immunologic clearance of HPV, therefore reducing the risk of cervical cancer. Women that had even a single Pap smear in their history had a lower incidence of cancer. [...] "A statistically significant decline in the HPV positivity rate correlated with the lifetime number of Pap smears received." ...|$|E
50|$|Therapies {{to treat}} {{inflammatory}} diseases include monoclonal antibodies that either neutralize <b>inflammatory</b> <b>cytokines</b> or their receptors.|$|R
50|$|In {{response}} to <b>inflammatory</b> <b>cytokines,</b> increasingly IL-6, the liver produces increased amounts of hepcidin. Hepcidin in turn causes increased internalisation of ferroportin molecules on cell membranes which prevents release from iron stores. <b>Inflammatory</b> <b>cytokines</b> {{also appear to}} affect other important elements of iron metabolism, including decreasing ferroportin expression, and probably directly blunting erythropoiesis by decreasing {{the ability of the}} bone marrow to respond to erythropoietin.|$|R
50|$|Caspase-1/Interleukin-1 {{converting}} enzyme (ICE) is an evolutionarily conserved {{enzyme that}} proteolytically cleaves other proteins, {{such as the}} precursors of the <b>inflammatory</b> <b>cytokines</b> interleukin 1β and interleukin 18 {{as well as the}} pyroptosis inducer Gasdermin D, into active mature peptides. It plays a central role in cell immunity as an inflammatory response initiator. Once activated through formation of an inflammasome complex, it initiates a proinflammatory response through the cleavage and thus activation of the two <b>inflammatory</b> <b>cytokines,</b> interleukin 1β (IL-1β) and interleukin 18 (IL-18) as well as pyroptosis, a programmed lytic cell death pathway, through cleavage of Gasdermin D. The two <b>inflammatory</b> <b>cytokines</b> activated by Caspase-1 are excreted from the cell to further induce the inflammatory response in neighboring cells.|$|R
50|$|Bacterial antigens stimulate {{white blood}} cells to release MIF into the blood stream. The {{circulating}} MIF binds to CD74 on other immune cells to trigger an acute immune response. Hence, MIF is classified as an <b>inflammatory</b> <b>cytokine.</b> Furthermore, glucocorticoids also stimulate {{white blood cells}} to release MIF and hence MIF partially counteracts the inhibitory effects that glucocorticoids have on the immune system. Finally trauma activates the anterior pituitary gland to release MIF.|$|E
50|$|A {{more recent}} area of {{research}} has been the examination of autosomal dominant polycystic kidney disease. Li’s lab {{was the first to}} propose, based on both experimental evidence and computational modeling, that the autosomal dominancy of this disease can be a result of positive feedback loops in <b>inflammatory</b> <b>cytokine</b> signaling and polycystin regulation, as opposed to obligatory second-hit mutations. They have also identified a tissue hypertrophy pathway as the direct downstream target for the mechanosensory activity of polycystins.|$|E
50|$|Like {{perivascular}} microglia, juxtavascular microglia can {{be distinguished}} mainly by their location. Juxtavascular microglia are found making {{direct contact with the}} basal lamina wall of blood vessels but are not found within the walls. Like perivascular cells, they express MHC class II proteins even at low levels of <b>inflammatory</b> <b>cytokine</b> activity. Unlike perivascular cells, but similar to resident microglia, juxtavascular microglia do not exhibit rapid turnover or replacement with myeloid precursor cells on a regular basis.|$|E
50|$|It is also {{predicted}} that {{the high level of}} <b>inflammatory</b> <b>cytokines</b> in the testis contributes to immune privilege.|$|R
30|$|The {{purpose of}} this study was to measure <b>inflammatory</b> <b>cytokines</b> in {{synovial}} fluid preoperatively and at 3 to 4  days after ACL reconstruction surgery and to investigate the correlation between each cytokine and the functional recovery status at 3  months postoperatively. The hypothesis of this study was that the levels of <b>inflammatory</b> <b>cytokines</b> in synovial fluid are inversely correlated with the functional recovery of the patient at 3  months after surgery.|$|R
40|$|<b>Inflammatory</b> <b>cytokines</b> play {{important}} roles {{in a variety of}} pathophysiological changes associated with traumatic injury and demyelinating disorders in the peripheral nervous system. After sciatic nerve injury, proinflammatory cytokines such as interleukin 1 β (IL- 1 β), interleukin- 6 (IL- 6) and tumor necrosis factor-α (TNFα) are produced by and act on neurons, Schwann cells, and infiltrating inflammatory cells at the lesion site. Underlying these processes is receptor-mediated activation of intracellular signaling pathways that regulate cell differentiation and proliferation and synthesis of axon and myelin components. This review focuses on roles of <b>inflammatory</b> <b>cytokines</b> in the degeneration and regeneration of the peripheral nerve. In addition, we describe here altered expression of <b>inflammatory</b> <b>cytokines</b> in gradually elongated rat sciatic nerves. This experimental model, which is devoid of Wallerian degeneration, provides insights into the involvement of <b>inflammatory</b> <b>cytokines</b> in the maintenance of myelinated axons. Based on the findings obtained from nerve elongation models and those from conventional nerve injury models, we discuss the molecular mechanism that ensures the integrity of the peripheral nerve. © 2011 by Nova Science Publishers, Inc. All rights reserved...|$|R
50|$|Kaposi's sarcoma-associated {{herpesvirus}} (KSHV) is {{the eighth}} human herpesvirus; its formal name {{according to the}} International Committee on Taxonomy of Viruses (ICTV) is HHV-8. Like other herpesviruses, its informal name (KSHV) is used interchangeably with its ICTV name. This virus causes Kaposi's sarcoma, a cancer commonly occurring in AIDS patients, as well as primary effusion lymphoma, some types of multicentric Castleman's disease and KSHV <b>inflammatory</b> <b>cytokine</b> syndrome. It is one of seven currently known human cancer viruses, or oncoviruses.|$|E
50|$|The general {{consensus}} in the literature is that TGF-β stimulates resting monocytes and inhibits activated macrophages. For monocytes, TGF-β {{has been shown to}} function as a chemoattractant as well as an upregulator of inflammatory response. However, TGF-β has also been shown to downregulate <b>inflammatory</b> <b>cytokine</b> production in monocytes and macrophages, likely by the aforementioned inhibition of NF-κB. This contradiction {{may be due to the}} fact that the effect of TGF-β has been shown to be highly context-dependent.|$|E
50|$|A proinflammatory {{cytokine}} or {{more simply}} an <b>inflammatory</b> <b>cytokine</b> {{is a type}} of signaling molecule (a cytokine) that is excreted from immune cells like helper T cells (Th) and macrophages, and certain other cell types that promote inflammation. They include interleukin-1 (IL-1), IL-12, and IL-18, tumor necrosis factor (TNF), interferon gamma (IFN-gamma), and granulocyte-macrophage colony stimulating factor and {{play an important role in}} mediating the innate immune response. Inflammatory cytokines are predominately produced by and involved in the upregulation of inflammatory reactions.|$|E
40|$|Proinflammatory cytokines play a {{pathogenic}} role in {{congestive heart}} failure. In this study, {{the effect of}} peritoneal dialysis treatment on <b>inflammatory</b> <b>cytokines</b> levels in refractory congestive heart failure patients was investigated. During the treatment, the patients reached a well-tolerated edema-free state and demonstrated significant improvement in NYHA functional class. Brain natriuretic peptide decreased significantly after 3 months of treatment and remained stable at 6 months. C-reactive protein, a plasma marker of inflammation, decreased significantly following the treatment. Circulating <b>inflammatory</b> <b>cytokines</b> TNF-α and IL- 6 decreased significantly after 3 months of peritoneal dialysis treatment and remained low at 6 months. The reduction in circulating <b>inflammatory</b> <b>cytokines</b> levels may be {{partly responsible for the}} efficacy of peritoneal dialysis for refractory congestive heart failure...|$|R
30|$|Hyperglycemia {{triggers}} and amplifies {{a cascade}} of inflammatory responses. Hyperglycemia facilitates production of superoxide anions through activation of {{nicotinamide adenine dinucleotide phosphate}} (NADPH) oxidase [5, 6]. Superoxide anions in turn trigger production of <b>inflammatory</b> <b>cytokines,</b> such as interleukin (IL)- 1 β, IL- 6, or tumor necrosis factor (TNF)-α [7], which augment both inflammatory responses and insulin resistance. Meanwhile, insulin exhibits anti-inflammatory actions by reducing production of <b>inflammatory</b> <b>cytokines</b> and reactive oxygen species [8].|$|R
3000|$|... {{anti-inflammatory}} effect {{resulting in a}} decrease of hepatic inflammation and <b>inflammatory</b> <b>cytokines,</b> possibly {{as a result of}} reduced tissue damage [56].|$|R
